Glucagon-like peptide-1 therapies in athletes: a framework beyond weight loss

Glucagon-like peptide-1 (GLP-1)–based therapies have transformed obesity treatment, but their increasing relevance to athletic populations raises questions that cannot be resolved using conventional weight management endpoints alone. In athletes, lower body weight does not necessarily imply improved body composition, health, or performance, particularly when pharmacological appetite suppression intersects with high exercise-related energy expenditure and sport-specific pressures surrounding leanness or weight. This perspective proposes an athlete-centered framework for interpreting GLP-1–based therapy across four interconnected domains: energy availability and nutritional adequacy; preservation of lean mass and functional capacity; recovery and sport-specific performance; and eating behavior, including vulnerability to dietary rigidity and disordered eating. This perspective introduces the GLP-1–Energy Availability–Performance (GEP) Framework, in which treatment effects on appetite, satiety, food reward, gastrointestinal tolerance, and dietary intake interact with training load, sport characteristics, and individual vulnerability. Rather than assuming either benefit or harm, this perspective argues that treatment success in athletes should be judged by whether clinically appropriate weight management can occur while preserving adequate fueling, lean tissue, recovery, psychological health, and sport-specific function. Direct athlete-specific evidence remains limited; accordingly, the GEP Framework should be regarded as conceptual and hypothesis-generating rather than as a validated clinical model, and its proposed pathways require prospective testing in athletic populations.

Authors

Institutions

Publication Details

Journal
Academia Nutrition and Dietetics
Published
2026-11-12
DOI
https://doi.org/10.20935/acadnutr8618
Primary Topic
Regulation of Appetite and Obesity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Glucagon-like peptide-1 therapies in athletes: a framework beyond weight loss

Vincenzo Maria Romeo
Academia Nutrition and Dietetics
Regulation of Appetite and Obesity
article

Glucagon-like peptide-1 therapies in athletes: a framework beyond weight loss

Vincenzo Maria Romeo
article en

Abstract

Glucagon-like peptide-1 (GLP-1)–based therapies have transformed obesity treatment, but their increasing relevance to athletic populations raises questions that cannot be resolved using conventional weight management endpoints alone. In athletes, lower body weight does not necessarily imply improved body composition, health, or performance, particularly when pharmacological appetite suppression intersects with high exercise-related energy expenditure and sport-specific pressures surrounding leanness or weight. This perspective proposes an athlete-centered framework for interpreting GLP-1–based therapy across four interconnected domains: energy availability and nutritional adequacy; preservation of lean mass and functional capacity; recovery and sport-specific performance; and eating behavior, including vulnerability to dietary rigidity and disordered eating. This perspective introduces the GLP-1–Energy Availability–Performance (GEP) Framework, in which treatment effects on appetite, satiety, food reward, gastrointestinal tolerance, and dietary intake interact with training load, sport characteristics, and individual vulnerability. Rather than assuming either benefit or harm, this perspective argues that treatment success in athletes should be judged by whether clinically appropriate weight management can occur while preserving adequate fueling, lean tissue, recovery, psychological health, and sport-specific function. Direct athlete-specific evidence remains limited; accordingly, the GEP Framework should be regarded as conceptual and hypothesis-generating rather than as a validated clinical model, and its proposed pathways require prospective testing in athletic populations.

Academia Nutrition and DieteticsVol. 3(4)
University of Reggio Calabria (IT), University of Palermo (IT)
Good health and well-being
Regulation of Appetite and Obesity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon